Switch to:
Array BioPharma Inc (NAS:ARRY)
Other Long-Term Assets
$4.78 Mil (As of Sep. 2014)

Array BioPharma Inc's other long-term assets for the quarter that ended in Sep. 2014 was $4.78 Mil.

Array BioPharma Inc's quarterly other long-term assets declined from Mar. 2014 ($9.25 Mil) to Jun. 2014 ($9.22 Mil) and declined from Jun. 2014 ($9.22 Mil) to Sep. 2014 ($4.78 Mil).

Array BioPharma Inc's annual other long-term assets increased from Jun. 2012 ($-71.32 Mil) to Jun. 2013 ($4.63 Mil) and increased from Jun. 2013 ($4.63 Mil) to Jun. 2014 ($9.22 Mil).


Definition

Assets are presented on the balance sheet in order of their liquidity. If a company expects to sell or otherwise recognize the economic value of an asset within one year, the asset is generally classified as a current asset on the balance sheet. Cash on hand is a common current asset.

A long-term asset is an asset that a company expects to sell or otherwise recognize the economic value of after more than one year. Property, plant and equipment, and intangible assets are common long-term assets. Except those two items and current assets, the others we treated as "Other Long Term Assets".


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Array BioPharma Inc Annual Data

Jun05Jun06Jun07Jun08Jun09Jun10Jun11Jun12Jun13Jun14
Other Long-Term Assets 0.080.001.5032.1623.6420.473.11-71.324.639.22

Array BioPharma Inc Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
Other Long-Term Assets -71.322.86-73.602.554.639.339.439.259.224.78
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK